Capricor Therapeutics
CAPR
CAPR
108 hedge funds and large institutions have $239M invested in Capricor Therapeutics in 2024 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% more call options, than puts
Call options by funds: $33.1M | Put options by funds: $26.6M
12.39% more ownership
Funds ownership: 25.72% → 38.11% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
108
Holding in Top 10
1
Calls
$33.1M
Puts
$26.6M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$23.4M | |
| 3 | +$16.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.66M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.69M |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$3.89M | |
| 3 | -$3.81M | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.18M |
| 5 |
SC
Stempoint Capital
New York
|
-$1.42M |